Researchers at Purdue University have developed a technology that allows quantitative measurement of virus entry into host cells and determination of the effectiveness of reagents that inhibit entry. This technology also allows for the production of Ebola glycoprotein-pseudotyped retroviruses with .....
[Detail]
Patient-specific formulations improve efficacyPotentially fewer side effects compared to current delivery methodsApproach can potentially be extended to treat alkylosis or other ailments affecting body chemistry
[Detail]
